p53 is a transcriptional activator which has been implicated as a key regulator of neuronal cell death after acute injury. We have shown previously that p53-mediated neuronal cell death involves a Bax-dependent activation of caspase 3; however, the transcriptional targets involved in the regulation of this process have not been identified. In the present study, we demonstrate that p53 directly upregulates Apaf1 transcription as a critical step in the induction of neuronal cell death. Using DNA microarray analysis of total RNA isolated from neurons undergoing p53-induced apoptosis a 5–6-fold upregulation of Apaf1 mRNA was detected. Induction of neuronal cell death by camptothecin, a DNA-damaging agent that functions through a p53-dependent mechanism, resulted in increased Apaf1 mRNA in p53-positive, but not p53-deficient neurons. In both in vitro and in vivo neuronal cell death processes of p53-induced cell death, Apaf1 protein levels were increased. We addressed whether p53 directly regulates Apaf1 transcription via the two p53 consensus binding sites in the Apaf1 promoter. Electrophoretic mobility shift assays demonstrated p53–DNA binding activity at both p53 consensus binding sequences in extracts obtained from neurons undergoing p53-induced cell death, but not in healthy control cultures or when p53 or the p53 binding sites were inactivated by mutation. In transient transfections in a neuronal cell line with p53 and Apaf1 promoter–luciferase constructs, p53 directly activated the Apaf1 promoter via both p53 sites. The importance of Apaf1 as a p53 target gene in neuronal cell death was evaluated by examining p53-induced apoptotic pathways in primary cultures of Apaf1-deficient neurons. Neurons treated with camptothecin were significantly protected in the absence of Apaf1 relative to those derived from wild-type littermates. Together, these results demonstrate that Apaf1 is a key transcriptional target for p53 that plays a pivotal role in the regulation of apoptosis after neuronal injury.
Skip Nav Destination
Article navigation
15 October 2001
Article Contents
Article|
October 08 2001
APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death
Andre Fortin,
Andre Fortin
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Search for other works by this author on:
Sean P. Cregan,
Sean P. Cregan
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Search for other works by this author on:
Jason G. MacLaurin,
Jason G. MacLaurin
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Search for other works by this author on:
Neena Kushwaha,
Neena Kushwaha
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Search for other works by this author on:
Emma S. Hickman,
Emma S. Hickman
3Department of Experimental Oncology, European Institute of Oncology, 20141 Milan, Italy
Search for other works by this author on:
Charlie S. Thompson,
Charlie S. Thompson
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Search for other works by this author on:
Antoine Hakim,
Antoine Hakim
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Search for other works by this author on:
Paul R. Albert,
Paul R. Albert
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
2Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Search for other works by this author on:
Francesco Cecconi,
Francesco Cecconi
4Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, Italy
Search for other works by this author on:
Kristian Helin,
Kristian Helin
3Department of Experimental Oncology, European Institute of Oncology, 20141 Milan, Italy
Search for other works by this author on:
David S. Park,
David S. Park
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
2Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Search for other works by this author on:
Ruth S. Slack
Ruth S. Slack
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
2Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Search for other works by this author on:
Andre Fortin
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Sean P. Cregan
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Jason G. MacLaurin
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Neena Kushwaha
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Emma S. Hickman
3Department of Experimental Oncology, European Institute of Oncology, 20141 Milan, Italy
Charlie S. Thompson
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Antoine Hakim
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Paul R. Albert
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
2Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Francesco Cecconi
4Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, Italy
Kristian Helin
3Department of Experimental Oncology, European Institute of Oncology, 20141 Milan, Italy
David S. Park
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
2Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Ruth S. Slack
1Ottawa Health Research Institute - Neuroscience, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
2Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H-8M5, Canada
Address correspondence to Ruth S. Slack, Ottawa Health Research Institute - Neuroscience, University of Ottawa, 451 Smyth Rd., Ottawa, ON K1H-8M5, Canada. Tel.: (613) 562-5800. Fax: (613) 562-5403. E-mail: [email protected]
Andre Fortin and Sean Cregan contributed equally to this work.
*
Abbreviations used in this paper: EMSA, electrophoretic mobility shift assay; MOI, multiplicity of infection; RT, reverse transcription.
Received:
May 31 2001
Revision Received:
August 17 2001
Accepted:
September 10 2001
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2001
J Cell Biol (2001) 155 (2): 207–216.
Article history
Received:
May 31 2001
Revision Received:
August 17 2001
Accepted:
September 10 2001
Citation
Andre Fortin, Sean P. Cregan, Jason G. MacLaurin, Neena Kushwaha, Emma S. Hickman, Charlie S. Thompson, Antoine Hakim, Paul R. Albert, Francesco Cecconi, Kristian Helin, David S. Park, Ruth S. Slack; APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death . J Cell Biol 15 October 2001; 155 (2): 207–216. doi: https://doi.org/10.1083/jcb.200105137
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement